Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
GLP-1 Receptor Agonist Exposure During Pregnancy: A Systematic Review and Meta-Analysis of Adverse Pregnancy Outcomes
Stimulant-containing versions (like the caffeine in green tea extract) may cause jitteriness, a faster heartbeat, or trouble sleeping in people sensitive to caffeine, especially above the typical 400 mg daily threshold
Blue Cross Blue Shield of Michigan GLP-1 Coverage Changes Explained Understanding the New Coverage Changes As of August 1, 2024, Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network (BCN) are altering their coverage for GLP-1 receptor agonists, which include popular weight loss medications like Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide)
doi:10.1111/j.1365-2133.2011.10650.x
However, recent data from Omada Insights Labs ANSWERS Initiative suggests that medication persistence, rather than early discontinuation, is key to GLP-1 cost containment and ROI
